Vinay Prasad is poised to become the director of CBER at the FDA, a role crucial for vaccine approval. His past statements show opposition to COVID vaccines for children, concerns over U.S. vaccination rates, and belief in loosening manufacturer liability. Critics argue his views may exacerbate vaccine hesitancy, undermining public health initiatives.
